Data / Form D filings / MicroPhage Inc
MicroPhage Inc: Form D filings
MicroPhage Inc, a biotechnology company in Longmont, CO, filed 9 Form D notices with the SEC in 2011. The latest, on October 19, 2011, reports $6 million sold of a $12 million offering to 1 investor.
Find out what MicroPhage Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2400 TRADE CENTRE AVENUE, Longmont, CO, 80503
- Phone
- (303) 652-5070
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1528424
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 19, 2011 | New notice | $12,000,000 | $6,000,000 | $6,000,000 | 1 | Oct 7, 2011 | sec.gov |
| Sep 30, 2011 | New notice | $6,446,543 | $6,446,543 | $0 | 90 | Mar 4, 2011 | sec.gov |
| Sep 30, 2011 | New notice | $3,113,715 | $3,113,715 | $0 | 45 | Jun 15, 2010 | sec.gov |
| Sep 30, 2011 | New notice | $8,514,449 | $8,514,449 | $0 | 91 | May 31, 2009 | sec.gov |
| Sep 29, 2011 | New notice | $1,535,452 | $1,535,452 | $0 | 26 | Oct 15, 2008 | sec.gov |
| Sep 29, 2011 | New notice | $2,300,962 | $2,300,962 | $0 | 47 | Mar 31, 2008 | sec.gov |
| Sep 29, 2011 | New notice | $2,511,855 | $2,511,855 | $0 | 51 | Jul 31, 2007 | sec.gov |
| Sep 29, 2011 | New notice | $1,019,190 | $1,019,190 | $0 | 29 | Dec 29, 2006 | sec.gov |
| Sep 29, 2011 | New notice | $3,705,443 | $3,705,443 | $0 | 45 | May 13, 2005 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Larry Gary Gold | Director | |
| Lynn Gary Taussig | Director | |
| Mel Gary Schatz | Director | |
| R. Gary Mesch | Director | |
| Donald Gary Mooney | Executive Officer, Director | |
| Mark Gary Schwartz | Director | |
| Rick Gary Norling | Director |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Oct 17, 2011 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MicroPhage Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.